ACE Inhibitor and Angiotensin II Type 1 Receptor Antagonist Therapies in Elderly Patients with Diabetes MellitusAre They Underutilized?

被引：0
作者：
Lamioko Shika Pappoe
Wolfgang C. Winkelmayer
机构：
[1] Harvard Medical School,Renal Division, Department of Medicine, Brigham and Women’s Hospital
[2] Harvard Medical School,Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital
[3] Brigham and Women’s Hospital,Division of Pharmacoepidemiology and Pharmacoeconomics
来源：
Drugs & Aging | 2010年 / 27卷
关键词：
Losartan; Ramipril; American Diabetes Association; Medicare Beneficiary; Diabetic Kidney Disease;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Diabetes mellitus is highly prevalent in older adults in the industrialized world. These patients are at high risk of complications from diabetes, including diabetic kidney disease. ACE inhibitors and their newer cousins, angiotensin II type 1 receptor antagonists (angiotensin receptor blockers [ARBs]), are powerful medications for the prevention of progression of diabetic renal disease.
引用
收藏
页码：87 / 94
页数：7
相关论文
共 80 条
[1]  
Geiss LS(1993)Surveillance for diabetes mellitus: United States, 1980–1989 MMWR CDC Surveill Summ 42 1-20
[2]  
Herman WH(2007)Racial differences in trends of end-stage renal disease, by primary diagnosis: United States, 1994–2004 MMWR Morb Mortal Wkly Rep 56 253-6
[3]  
Goldschmid MG(2001)Projection of diabetes burden through 2050: impact of changing demography and disease prevalence in the US Diabetes Care 24 1936-40
[4]  
Boyle JP(1998)Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in US adults: the Third National Health and Nutrition Examination Survey, 1988–1994 Diabetes Care 21 518-24
[5]  
Honeycutt AA(2004)The evolving diabetes burden in the United States Ann Intern Med 140 945-50
[6]  
Narayan KM(2008)Standards of medical care for patients with diabetes mellitus Diabetes Care 31 S55-60
[7]  
Harris MI(2003)Economic costs of diabetes in the US in 2002 Diabetes Care 26 917-32
[8]  
Flegal KM(1986)Beneficial effects of angiotensin converting enzyme inhibition on renal function in patients with diabetic nephropathy Br Med J (Clin Res Ed) 293 471-4
[9]  
Cowie CC(1986)Effect of captopril on kidney function in insulin-dependent diabetic patients with nephropathy Br Med J (Clin Res Ed) 293 467-70
[10]  
Engelgau MM(1996)Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus: a 7-year follow-up study Arch Intern Med 156 286-9
12345678